Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals.

Allen GFG, McDonald TJ, Kyle S, Keysell N

Open source

DOI
10.1093/rap/rkag103
Published
2026
Container
Rheumatology advances in practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rap/rkag103,
  title = {Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals.},
  author = {Allen GFG and McDonald TJ and Kyle S and Keysell N},
  year = {2026},
  journal = {Rheumatology advances in practice},
  doi = {10.1093/rap/rkag103},
  url = {https://doi.org/10.1093/rap/rkag103}
}

RIS

TY  - JOUR
TI  - Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals.
AU  - Allen GFG
AU  - McDonald TJ
AU  - Kyle S
AU  - Keysell N
PY  - 2026
JO  - Rheumatology advances in practice
DO  - 10.1093/rap/rkag103
UR  - https://doi.org/10.1093/rap/rkag103
ER  - 

APA

GFG, A., TJ, M., S, K., & N, K. (2026). Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals.. Rheumatology advances in practice. https://doi.org/10.1093/rap/rkag103

Source records